SIRPA and neoplasm: Flow cytometry analysis at 24 h after tumor cell vaccination revealed that SIRPα+ cells consisted of mainly CD11c−CD11b+ non-DC myeloid cell and CD11c+ DC populations, and the latter can be further divided into CD11b+ and CD11b− DC subsets (Fig. 4a).